Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-46,979
Closed -$1.3M 427
2020
Q2
$1.3M Sell
46,979
-2,748
-6% -$59.6K 0.08% 102
2020
Q1
$888K Buy
49,727
+10,225
+26% +$247K 0.07% 104
2019
Q4
$990K Sell
39,502
-7,351
-16% -$161K 0.06% 96
2019
Q3
$836K Buy
46,853
+13,732
+41% +$286K 0.05% 89
2019
Q2
$729K Sell
33,121
-7,780
-19% -$222K 0.04% 91
2019
Q1
$1.25M Buy
40,901
+16,516
+68% +$412K 0.06% 102
2018
Q4
$563K Buy
+24,385
New +$758K 0.03% 127

Other funds holding HCM

TOBAM's HCM Position: Q3 2020 in Review

TOBAM sold out of HUTCHMED (HCM) in Q3 2020, closing a stake of 46,979 shares — an estimated $1.3M sold.

TOBAM first reported a position in HCM in Q4 2018 and held it in 7 quarters. The position peaked at $1.3M in Q2 2020. 125 funds tracked by Wall St. Rank hold HCM as of Q3 2020.

  • TOBAM reported no remaining HUTCHMED position as of Q3 2020 after selling out during the quarter.
  • TOBAM sold 46,979 HUTCHMED shares in Q3 2020, an estimated $1.3M.
  • TOBAM first reported a position in HUTCHMED in Q4 2018 and held it in 7 quarters.
  • TOBAM's HUTCHMED position peaked at $1.3M in Q2 2020.
  • 125 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2020.

Based on TOBAM's 13F filing for Q3 2020, filed 12 Nov 2020.